Results per Page:
Out of pocket costs and patient outcomes in EGFR and ALK positive NSCLC
From the Goulart and Ramsey Group
Survival of cancer patients who did not meet standard trial eligibility
From the Percival Group, Public Health Sciences Division
Big gains in bone marrow transplant survival since mid-2000s
Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
Bone marrow transplant survival rates recognized nationally
Fred Hutch BMT program at SCCA earns national recognition for 6th consecutive year
How mutations in a single gene alter the course of a deadly brain cancer
New laboratory study of glioma links more aggressive immune response to poorer prognosis
Patients treated at cancer centers live longer: study
Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’
Potential breakthrough in pancreatic cancer treatment
Sunil Hingorani-led study breaks unique tumor defense, extends survival in mice by 70 percent; initial human studies under way
SCCA survival rates top most cancer programs nationwide
According to data compiled by the National Cancer Data Base, survival rates among patients treated for eight types of cancer top other programs accredited by Commission on Cancer
Transplantation refinements boost long-term survival of blood cancers
Clinical Research Division study shows 41 percent drop in post-transplant deaths compared to mid-1990s
Othus joins Hutchinson Center biostatisticians
Harvard graduate applies analytic skills to clinical trials
Sanders gives ALL children hope
For 'Sanders' babies' with acute lymphoblastic leukemia, total-body radiation therapy followed by bone-marrow transplantation provides dramatic cure rates for infants